MS News: June 2015


There’s only one topic in the Highlight! part of the good news list this month. In my view, more private firms should be involved in clinical research, sponsorships of medical institutions etc. In essence, it’s in everyone’s best interests, i.e. everyone’s health, theirs included.

What’s your view on this? Answer below!


  1. Google X is developing a wearable for clinical research


  1. Grey matter atrophy in the thoracic spinal cord is associated with disability in patients with multiple sclerosis
  2. MedDay Reveals Promising Data on Progressive Multiple Sclerosis Therapy
  3. Biotin benefits ‘clinically relevant’ in progressive multiple sclerosis
  4. Researchers Offer New Insights into the Link Between Multiple Sclerosis and Specific Autoantibodies
  5. Brevard ophthalmologist: Multiple sclerosis affects vision
  6. Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis
  7. Protein That Clears Brain of Debris May Be Link to Multiple Sclerosis, Alzheimer’s Disease …
  8. New risk gene that triggers multiple sclerosis
  9. Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
  10. Gene variants linked to MS disrupt key regulator of inflammation
  11. Scientists Discover A New Link Between The Brain And The Immune System
  12. Innate Lymphoid Cell Identified As Cause of Multiple Sclerosis Gender Differences
  13. Carriers of Genetic Mutation at 1.7 Times Greater Risk for Multiple Sclerosis
  14. Multiple Sclerosis Patients Have Less Vascular Comorbidities
  15. Comorbidities in Multiple Sclerosis May Influence Pain
  16. Resetting the Immune System may halt Multiple Sclerosis progression
  17. Landmark Study Finds Previously Unknown Link Between The Brain And Immune System

Clinical trials

  1. MediciNova Announces Update On Phase 2b Trial of MN-166 (Ibudilast) Involving 255 Progressive …
  2. MedDay Reports Additional Positive Data of its Pivotal Phase III Study With MD1003 in Patients …
  3. Review Suggests PEG-IFN Therapy for Relapsing-Remitting Multiple Sclerosis Significantly …
  4. RedHill Biopharma Enrolls Final RRMS Patient in RHB-104 Clinical Trial
  5. Adamas Begins Phase 2 Clinical Trial Assessing ADS-5102 for Treating Multiple Sclerosis …

Medical treatment news

  1. Once-daily Oral AUBAGIO Therapy For Canada’s First Nations People To Be Reimbursed
  2. Canadian Drug Expert Committee Recommends MS Therapy LEMTRADA For Public Coverage
  3. Canadians with Multiple Sclerosis One Step Closer to Accessing LEMTRADA®
  4. Fampyra: Multiple Sclerosis patient welcomes claims that HSE looks set to fund a miracle drug
  5. Reversing Multiple Sclerosis Damage with Topical Medications
  6. Non-Insured Health Benefits Program Approves AUBAGIO(TM) for Relapsing Remitting MS
  7. Teva Ruling Clears Way for Generic Version of Multiple Sclerosis Drug
  8. Researchers Suggest Short Transition Period Between Natalizumab and Fingolimod Therapies to …
  9. LMU Researchers Identify Biomarker BCMA to Measure MS Severity
  10. Revised MRI Guidelines for Multiple Sclerosis Stress Consistency

Holistic treatment news

  1. Study finds scant evidence that medical marijuana helps many illnesses
  2. Study Shows Vitamin D Supplementation in Pregnant Women With MS Positively Impacts Disease …
  3. Georgia’s medical marijuana cards launch Tuesday
  4. Massage for Multiple Sclerosis patients
  5. Most MS Survey Respondents Favor Legal Marijuana Access For Medical Use
  6. Hypnosis for Multiple Sclerosis

MS Organisations

  1. News about multiple sclerosis from the National Multiple Sclerosis Society


  1. 13 Tips for Getting the Best MS Care Possible
  2. FDA Taps Online Patient Database To Gain Access To Patient-Reported MS Health Data
  3. Race After Race, Teenager Crosses Finish Line, Then Collapses
  4. The Multiple Sclerosis Association of America Launches Updated My MS Manager™ Mobile …
  5. The benefits of a positive approach to multiple sclerosis
  6. Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis

Business news

  1. Research and Markets: Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H1 2015
  2. Research and Markets: Secondary Progressive Multiple Sclerosis (SPMS) Pipeline Insights 2015
  3. Research report explores the secondary progressive multiple sclerosis – pipeline market review to …
  4. Biogen and SELF Join Together to Help Women With Relapsing Multiple Sclerosis Re-imagine …
  5. Multiple Sclerosis Drugs Market – Global Industry Analysis and Forecast to 2020
  6. 4D Pharma Says Has Identified Potential Multiple Sclerosis Candidate
  7. Receptos Could Be Acquired at $348 a Share
  8. Jack Osbourne and Teva Launch New Educational Multiple Sclerosis Website
  9. Novartis Pharma Program Helping Young People with MS Get And Keep Jobs

©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2015. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

One thought on “MS News: June 2015

Your thoughts?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.